The effects of β-chemokines on CFU-A colony formation in vitro
Chemokine, 100 ng/mL . | Systematic name . | Colony growth (%)* . | Receptors used . |
---|---|---|---|
MIP-1β | CCL4 | 75.0 ± 18.8 | CCR1, CCR5, D6 |
RANTES | CCL5 | 111.4 ± 26.3 | CCR1, CCR3, CCR5, D6 |
MCP1 | CCL2 | 112.6 ± 18.8 | CCR1, CCR2, D6 |
MCP2 | CCL8 | 93.4 ± 9.4 | CCR1, CCR2, CCR5, D6 |
HCC1 | CCL14 | 93.4 ± 9.4 | CCR1 |
HCC2 | CCL15 | 88.9 ± 20.8 | CCR1, CCR3 |
HCC4 | CCL16 | 102.2 ± 18.2 | CCR1 |
MPIF1 | CCL23 | 76.3 ± 16.5 | CCR1 |
Eotaxin | CCL11 | 107.9 ± 25.7 | CCR3, D6 |
MDC | CCL22 | 83.3 ± 17.1 | CCR4 |
MIP-3α | CCL20 | 104.5 ± 34.8 | CCR6 |
SLC | CCL21 | 109.2 ± 11.0 | CCR7, CCR11 |
I309 | CCL1 | 106.5 ± 43.1 | CCR8 |
TECK | CCL25 | 101.3 ± 12.8 | CCR9, CCR11 |
ESkine | CCL27 | 90.8 ± 27.7 | CCR10 |
Chemokine, 100 ng/mL . | Systematic name . | Colony growth (%)* . | Receptors used . |
---|---|---|---|
MIP-1β | CCL4 | 75.0 ± 18.8 | CCR1, CCR5, D6 |
RANTES | CCL5 | 111.4 ± 26.3 | CCR1, CCR3, CCR5, D6 |
MCP1 | CCL2 | 112.6 ± 18.8 | CCR1, CCR2, D6 |
MCP2 | CCL8 | 93.4 ± 9.4 | CCR1, CCR2, CCR5, D6 |
HCC1 | CCL14 | 93.4 ± 9.4 | CCR1 |
HCC2 | CCL15 | 88.9 ± 20.8 | CCR1, CCR3 |
HCC4 | CCL16 | 102.2 ± 18.2 | CCR1 |
MPIF1 | CCL23 | 76.3 ± 16.5 | CCR1 |
Eotaxin | CCL11 | 107.9 ± 25.7 | CCR3, D6 |
MDC | CCL22 | 83.3 ± 17.1 | CCR4 |
MIP-3α | CCL20 | 104.5 ± 34.8 | CCR6 |
SLC | CCL21 | 109.2 ± 11.0 | CCR7, CCR11 |
I309 | CCL1 | 106.5 ± 43.1 | CCR8 |
TECK | CCL25 | 101.3 ± 12.8 | CCR9, CCR11 |
ESkine | CCL27 | 90.8 ± 27.7 | CCR10 |
Results are expressed as the mean percentage (± SD) of colonies generated in the presence of chemokine compared with control plates. Results are representative of at least 5 experiments.